Histological evaluation of vertical laser channels from ablative fractional resurfacing: an ex vivo pig skin model.
Ablative fractional resurfacing (AFR) represents a new treatment potential for various skin conditions and new laser devices are being introduced. It is important to gain information about the impact of laser settings on the dimensions of the created laser channels for obtaining a safe and efficient treatment outcome. The aim of this study was to establish a standard model to document the histological tissue damage profiles after AFR and to test a new laser device at diverse settings. Ex vivo abdominal pig skin was treated with a MedArt 620, prototype fractional carbon dioxide (CO(2)) laser (Medart, Hvidovre, Denmark) delivering single microbeams (MB) with a spot size of 165 μm. By using a constant pulse duration of 2 ms, intensities of 1-18 W, single and 2-4 stacked pulses, energies were delivered in a range from 2-144 mJ/MB. Histological evaluations included 3-4 high-quality histological measurements for each laser setting (n = 28). AFR created cone-shaped laser channels. Ablation depths varied from reaching the superficial dermis (2 mJ, median 41 μm) to approaching the subcutaneous fat (144 mJ, median 1,943 μm) and correlated to the applied energy levels in an approximate linear relation (r(2) = 0.84, p < 0.001). The dermal ablation width increased slightly within the energy range of 4-144 mJ (median 163 μm). The thickness of the coagulation zone reached a plateau around 65 μm at energies levels above 16 mJ. The calculated volumes of ablated tissue increased with increasing energies. We suggest this ex vivo pig skin model to characterize AFR laser channels histologically.
Skovbølling Haak
Christina
C
Department of Dermatology D-92 Bispebjerg Hospital, University of Copenhagen, Bispebjerg Bakke 23, 2400, Copenhagen, NV, Denmark. christinahaak@dadlnet.dk
Illes
Monica
M
Paasch
Uwe
U
Hædersdal
Merete
M
D000818:Animals; D004195:Disease Models, Animal; D066298:In Vitro Techniques; D053685:Laser Therapy; D054020:Lasers, Gas / Q000627:therapeutic use*; D058629:Plasma Skin Regeneration; D012867:Skin / Q000033:anatomy & histology*; D012871:Skin Diseases / Q000601:surgery*; D013552:Swine
Clin Dermatol. 2007 Sep-Oct;25(5):480-6
17870526
Lasers Surg Med. 2008 Feb;40(2):113-23
18306165
Facial Plast Surg. 2009 Nov;25(4):245-51
19924597
Lasers Surg Med. 2007 Feb;39(2):87-95
17115384
J Dtsch Dermatol Ges. 2009 Apr;7(4):301-8
18761608
Lasers Surg Med. 2008 Mar;40(3):171-7
18366083
Lasers Med Sci. 2010 Jan;25(1):137-44
19787413
Lasers Surg Med. 2006 Mar;38(3):169-76
16532440
Lasers Surg Med. 2006 Feb;38(2):142-9
16392146
J Biomed Opt. 2009 Nov-Dec;14(6):064044
20059282
Dermatol Surg. 2009 Oct;35(10):1445-61
19686366
Lasers Surg Med. 2009 Nov;41(9):634-42
19816914
Skin Pharmacol Appl Skin Physiol. 2000 Sep-Oct;13(5):229-34
10940812
Semin Cutan Med Surg. 2008 Mar;27(1):63-71
18486026
Lasers Surg Med. 2007 Feb;39(2):96-107
17311274
J Drugs Dermatol. 2009 Jan;8(1):17-20
19180891
Lasers Surg Med. 2005 Apr;36(4):270-80
15719420
Lasers Surg Med. 2004;34(5):426-38
15216537